These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 36253555)

  • 1. Allergen immunotherapy: past, present and future.
    Durham SR; Shamji MH
    Nat Rev Immunol; 2023 May; 23(5):317-328. PubMed ID: 36253555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublingual allergen immunotherapy: immunological mechanisms and prospects for refined vaccine preparation.
    O'Hehir RE; Sandrini A; Anderson GP; Rolland JM
    Curr Med Chem; 2007; 14(21):2235-44. PubMed ID: 17896972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of allergen-specific tolerance via mucosal routes.
    Mascarell L; Zimmer A; Van Overtvelt L; Tourdot S; Moingeon P
    Curr Top Microbiol Immunol; 2011; 352():85-105. PubMed ID: 21562971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synchronous immune alterations mirror clinical response during allergen immunotherapy.
    Renand A; Shamji MH; Harris KM; Qin T; Wambre E; Scadding GW; Wurtzen PA; Till SJ; Togias A; Nepom GT; Kwok WW; Durham SR
    J Allergy Clin Immunol; 2018 May; 141(5):1750-1760.e1. PubMed ID: 29128670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Specific immunotherapy using allergens apropos of specific immunotherapy by the sublingual route].
    Sabbah A
    Allerg Immunol (Paris); 1998 Sep; 30(7):221-8. PubMed ID: 9823421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines.
    Mascarell L; Van Overtvelt L; Moingeon P
    Immunol Allergy Clin North Am; 2006 May; 26(2):283-306, vii-viii. PubMed ID: 16701145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance-Phase Subcutaneous Immunotherapy with House Dust Mites Induces Cyclic Immunologic Effects.
    Chaoul N; Albanesi M; Giliberti L; Rossi MP; Nettis E; Di Bona D; Caiaffa MF; Macchia L
    Int Arch Allergy Immunol; 2019; 179(1):37-42. PubMed ID: 30921804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergen immunotherapy, routes of administration and cytokine networks: an update.
    Cuppari C; Leonardi S; Manti S; Filippelli M; Alterio T; Spicuzza L; Rigoli L; Arrigo T; Lougaris V; Salpietro C
    Immunotherapy; 2014; 6(6):775-86. PubMed ID: 25186606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance.
    Berings M; Karaaslan C; Altunbulakli C; Gevaert P; Akdis M; Bachert C; Akdis CA
    J Allergy Clin Immunol; 2017 Nov; 140(5):1250-1267. PubMed ID: 28941667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell responses during allergen-specific immunotherapy.
    Maggi E; Vultaggio A; Matucci A
    Curr Opin Allergy Clin Immunol; 2012 Feb; 12(1):1-6. PubMed ID: 22157159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics and dynamic evaluation of specific immunotherapy.
    Pereira C; Botelho F; Tavares B; Lourenço C; Baeta C; Palma-Carlos AG; Lima J; Chieira C
    Eur Ann Allergy Clin Immunol; 2004 Dec; 36(10):375-86. PubMed ID: 15662966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EAACI Allergen Immunotherapy User's Guide.
    Alvaro-Lozano M; Akdis CA; Akdis M; Alviani C; Angier E; Arasi S; Arzt-Gradwohl L; Barber D; Bazire R; Cavkaytar O; Comberiati P; Dramburg S; Durham SR; Eifan AO; Forchert L; Halken S; Kirtland M; Kucuksezer UC; Layhadi JA; Matricardi PM; Muraro A; Ozdemir C; Pajno GB; Pfaar O; Potapova E; Riggioni C; Roberts G; Rodríguez Del Río P; Shamji MH; Sturm GJ; Vazquez-Ortiz M
    Pediatr Allergy Immunol; 2020 May; 31 Suppl 25(Suppl 25):1-101. PubMed ID: 32436290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing therapies for peanut allergy.
    Bublin M; Breiteneder H
    Int Arch Allergy Immunol; 2014; 165(3):179-94. PubMed ID: 25531161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergen-specific immunosuppression by mucosal treatment with recombinant Ves v 5, a major allergen of Vespula vulgaris venom, in a murine model of wasp venom allergy.
    Winkler B; Bolwig C; Seppälä U; Spangfort MD; Ebner C; Wiedermann U
    Immunology; 2003 Nov; 110(3):376-85. PubMed ID: 14632666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches to allergen immunotherapy.
    Gunawardana NC; Durham SR
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):293-305. PubMed ID: 30025907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.
    Jutel M; Akdis M; Blaser K; Akdis CA
    Allergy; 2006 Jul; 61(7):796-807. PubMed ID: 16792576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune mechanisms of allergen-specific sublingual immunotherapy.
    Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L
    Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review on immunotherapy in airway allergen sensitised patients.
    van der Valk JP; de Jong NW; Gerth van Wijk R
    Neth J Med; 2015 Jul; 73(6):263-9. PubMed ID: 26228190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New strategies for allergen immunotherapy.
    Carnés J; Robinson DS
    Recent Pat Inflamm Allergy Drug Discov; 2008 Jun; 2(2):92-101. PubMed ID: 19075996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.